Home >  News >  Industry >  Pharma News >  JP Nadda addresses rising...

JP Nadda addresses rising cancer cases, medicine affordability

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-07-27 07:35 GMT   |   Update On 2024-08-05 19:03 GMT
Advertisement

New Delhi: Amid rising cancer cases in India, Health Minister JP Nadda ensured that the government is committed to providing affordable and accessible treatment. The Minister said this while replying to a supplementary questions during Question Hour in the Lok Sabha.

Nadda also noted that cancer cases are increasing annually by nearly 2.5 percent.

In men, cases of oral and lung cancer are on the up while more women are getting breast cancer, he added.

Advertisement
More than 15.5 lakh cancer cases are being registered every year, Nadda said.
"There is a list of 131 essential cancer medicines, which are in Schedule 1, (that) are monitored and (their) pricing is decided by the government. These are the commonly used medicines," Nadda said.
According to PTI, he said patients cumulatively saved around Rs 294 crore due to this price control.
"There are 28 combinations, which are not in this list but the NPPA (National Pharmaceutical Pricing Authority) and the government have controlled their pricing as well," he said.
"We have tried to make cancer drugs affordable," he added.
Responding to another question on healthcare infrastructure, Nadda said the government was apprised of the matter and expansion of medical colleges were happening so that there could be more doctors.
"There should be a balance in quality and quantity of medical education. We are trying to go as fast as we can but, at the same time, (we) do not want to compromise on the quality of medical doctors," he said.
Nadda informed the House that the number of medical colleges had gone up from 387 in 2014 to 731 at present while the number of MBBS seats rose from 51,348 seats to 1,12,112 (1.12 lakh) during the same period.
The number of postgraduate seats for medical students has gone up from 31,185 in 2014 to 72,627 at present, he added.
Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Biocon appoints Rajesh Umakant Shanoy as Company Secretary, Compliance Officer

JnJ bags USFDA nod for bladder cancer treatment Inlexzo

Indian Pharma Market Grows 8.7% in August, Records Rs 20,984 Crore Sales: PharmaTrac

NPPA Clarifies Pharma Data Tender Terms, Technical Presentations on Sept 19

Active Pharm Chemicals Loses Rs 2.17 Crore in API Supply Fraud, 4 Booked

Chemist Body Seeks Transition Period, GST Input Adjustment After Tax Cut, Writes to CM

Strides Pharma Science Singapore arm, Kenox Pharma partner to develop multiple nasal spray products for US

Novartis to buy Tourmaline Bio for USD 1.4 billion